ReEngage Therapeutics
Houston, US · Founded 2024 · Delaware corporation
Founders & leadership
TK
Thomas KimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$430K disclosed across 2 rounds · 2024–2025
▶$365KraisedJul 2025 · 6 investors · Other Health CareRule 506(b)
▶$365KraisedJul 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KimExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $365K
- Proceeds to insiders
- $25K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$65KraisedDec 2024 · 5 investors · Other Health CareRule 506(b)
▶$65KraisedDec 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KimExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $65K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ReEngage Therapeutics raised?
- ReEngage Therapeutics has disclosed $430K raised across 2 rounds.
- Where is ReEngage Therapeutics headquartered?
- ReEngage Therapeutics is headquartered in Houston, US.